BUY MBP PERTUZUMAB ERJETA 420MG/14ML(30MG/M VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. PERTUZUMAB is a medicine used in the treatment of HER2 positive breast cancer, and I want to explain pertuzumab in a way that helps you feel informed, supported and confident in your treatment plan. Starting pertuzumab can bring many questions, and it is normal to want to understand exactly why pertuzumab is being used and what to expect from it. My role as your pharmacist is to guide you through how pertuzumab works, how pertuzumab is given, and the important safety information you need to know while you are receiving pertuzumab.

Pertuzumab is a monoclonal antibody that specifically targets a protein on cancer cells called HER2. In HER2 positive breast cancer, the HER2 protein is overactive and sends constant signals telling cancer cells to grow and divide faster than normal. Pertuzumab attaches to a different part of the HER2 receptor than trastuzumab, and when pertuzumab binds, it blocks HER2 from pairing with other receptors on the cancer cell surface. This prevents the cancer cell from receiving the signals it needs to multiply. By blocking these pathways, pertuzumab slows cancer growth and makes the cancer more sensitive to other treatments given alongside pertuzumab.

Pertuzumab is almost always given together with trastuzumab and chemotherapy, because pertuzumab enhances the effects of these medicines. This combination is one of the most effective treatment approaches for HER2 positive breast cancer. Pertuzumab may be used before surgery, after surgery or in metastatic settings depending on your individual treatment plan.

Pertuzumab is given as an intravenous infusion. The first dose of pertuzumab is usually given slowly over a longer period while nurses monitor your heart rate, blood pressure, breathing and comfort levels. If you tolerate the first pertuzumab infusion well, future doses of pertuzumab are usually given more quickly. Pertuzumab infusions are repeated every three weeks in most treatment schedules.

Because pertuzumab targets HER2, and HER2 is also found in small amounts in heart tissue, pertuzumab can sometimes affect heart function. This is why you will have regular heart monitoring with echocardiograms or MUGA scans while you are receiving pertuzumab. These tests help ensure that pertuzumab remains safe for you. If you ever develop shortness of breath, swelling in your legs, new fatigue, palpitations or chest discomfort while taking pertuzumab, you should report these symptoms promptly.

Like all medications, pertuzumab can cause side effects. Not everyone experiences the same reactions, but it is important to know what may occur while receiving pertuzumab. One of the more common side effects of pertuzumab is diarrhea. This can happen early in treatment or later in the course of pertuzumab. You should stay well hydrated and let your care team know if diarrhea becomes persistent, as you may need supportive medication.

Hair loss can occur when pertuzumab is given with chemotherapy, though pertuzumab by itself does not usually cause hair loss. Fatigue is another common symptom for people receiving pertuzumab, especially when pertuzumab is combined with other cancer medicines. Mild skin rashes or dryness can also occur, and these can be managed with moisturisers or medicated creams if needed.

Some infusion related reactions can occur with pertuzumab. During or shortly after the pertuzumab infusion, you may experience chills, fever, headache, nausea or a feeling of tightness in the chest or throat. Nurses are trained to manage these reactions and will monitor you closely during each pertuzumab infusion. Many people have no infusion reactions after the first or second pertuzumab dose.

Because pertuzumab affects the immune system indirectly, infections may be slightly more common while receiving pertuzumab. You should notify your care team if you develop fever, persistent cough, sore throat, burning when urinating or any other symptoms of infection during pertuzumab therapy. It is always better to report early rather than wait.

Pertuzumab does not usually interact with many oral medicines because it is not processed through the liver the way tablets are. However, pertuzumab is almost always part of a combination cancer regimen, and your care team will check for interactions with the chemotherapy medicines given alongside pertuzumab.

While you are receiving pertuzumab, there are some important precautions. Pertuzumab can harm a developing baby, so pregnancy must be avoided throughout treatment and for several months after the final pertuzumab dose. Your doctor or pharmacist can discuss reliable contraception options if needed.

Even though pertuzumab is a powerful cancer medicine, many patients continue their daily activities around pertuzumab treatment. Some days will feel easier than others, but you are not alone in this process. Your doctors, nurses and I as your pharmacist will monitor your progress closely throughout your time on pertuzumab to ensure you remain safe and supported.

You are taking an important step in your cancer treatment by starting pertuzumab. Many people receiving pertuzumab experience significant improvements in their cancer outcomes, and you deserve to feel fully informed, reassured and cared for along the way. If at any point you have questions, concerns or changes in your symptoms while receiving pertuzumab, please let your care team know. I am here to support you through every phase of your pertuzumab treatment journey.